You have 9 free searches left this month | for more free features.

Rare Immune Disorders

Showing 9926 - 9950 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rhythm; Disorder Trial in Essen (Audiovisual distraction using 2d video glasses from HappyMed GmbH)

Completed
  • Rhythm; Disorder
  • Audiovisual distraction using 2d video glasses from HappyMed GmbH
  • Essen, NRW, Germany
    University Hospital Essen
Apr 29, 2021

Alcohol Use Disorder Trial in Palo Alto (Al-Anon Intensive Referral (AIR))

Completed
  • Alcohol Use Disorder
  • Al-Anon Intensive Referral (AIR)
  • Palo Alto, California
    VA Palo Alto Health Care System
May 4, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +13 more
  • Polatuzumab Vedotin
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Aug 23, 2022

Sleep Disorders in Patients : Pro-TSIC Study

Completed
  • Heart Failure
  • +2 more
    • Montpellier, France
      Uhmontpellier
    Dec 28, 2020

    CNS Lymphoma Trial in Duarte (procedure, biological, drug)

    Recruiting
    • Central Nervous System Lymphoma
    • Aspiration
    • +10 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in France (drug, procedure, behavioral)

    Recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Nebido® Testosterone Undecanoate 1000 Mg/4 mL Solution for Injection
    • +4 more
    • Besançon, France
    • +3 more
    Oct 18, 2021

    Healthy, Blindness Trial in Saint Genis Laval (Electrooculogram (EOG), Surface Electromyography (EMG), Electrodermal response)

    Recruiting
    • Healthy
    • Blindness
    • Electrooculogram (EOG)
    • +7 more
    • Saint Genis Laval, France
      Hospices Civils de Lyon
    Jul 19, 2021

    Corneal Epithelial Disorders Trial in United States (SJP-0035 Ophthalmic Solution, Vehicle of SJP-0035 Ophthalmic Solution)

    Completed
    • Corneal Epithelial Disorders
    • SJP-0035 Ophthalmic Solution
    • Vehicle of SJP-0035 Ophthalmic Solution
    • Little Rock, Arkansas
    • +16 more
    Mar 25, 2021

    Fibrosis Trial in Aarhus (Growth hormone, saline and GH receptor blockade (Pegvisomant))

    Recruiting
    • Fibrosis
    • Growth hormone, saline and GH receptor blockade (Pegvisomant)
    • Aarhus, Denmark
      Aarhus University
    Aug 31, 2021

    Is One Pass Enough for Diagnosis of Pancreatic Masses During

    Active, not recruiting
    • Pancreatic Cancer
    • EUS-FNB
    • Castellanza, Italy
      Humanitas-Mater Domini
    Jun 28, 2022

    Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Emphysema or COPD
    • CD3/CD19 negative hematopoietic stem cells
    • +6 more
    • Pittsburgh, Pennsylvania
    • +1 more
    Feb 9, 2022

    Malaria, Dengue Trial in Mae Sot (Mosquito bites)

    Recruiting
    • Malaria
    • Dengue
    • Mosquito bites
    • Mae Sot, Tak, Thailand
      Shoklo Malaria Research unit (SMRU)
    Aug 13, 2021

    cl[Nical Study of Succide Among Psychoactive Substance Use

    Not yet recruiting
    • Substance Use Disorders
    • drug screen
    • (no location specified)
    Nov 9, 2021

    Scleroderma, Systemic Trial in Strasbourg (Cone Beam Computed Tomography (CBCT))

    Terminated
    • Scleroderma, Systemic
    • Cone Beam Computed Tomography (CBCT)
    • Strasbourg, France
      Service de parodontologie
    Sep 13, 2021

    PTSDs, PTSD Trial in Toronto (Online Mindfulness-Based CBT & Trauma-Informed Yoga Intervention)

    Completed
    • Posttraumatic Stress Disorders
    • PTSD
    • Online Mindfulness-Based CBT & Trauma-Informed Yoga Intervention
    • Toronto, Ontario, Canada
      York University
    Jan 24, 2022

    Comorbidities and Coexisting Conditions, Healthy Trial in Manaus (Vaccine - ChAdOx1-S/nCoV-19 [recombinant])

    Active, not recruiting
    • Comorbidities and Coexisting Conditions
    • Healthy
    • Vaccine - ChAdOx1-S/nCoV-19 [recombinant]
    • Manaus, Amazonas, Brazil
      Fundação de Medicina Tropical Dr Heitor Vieira Dourado
    May 3, 2022

    IBD Trial in Kiel (Infliximab, Vedolizumab)

    Completed
    • IBD
    • Kiel, Germany
      Medical Department I, University Hospital Schleswig-Holstein
    Jun 30, 2022

    NSCLC Trial in Worldwide (Nivolumab)

    Completed
    • Non-Small Cell Lung Cancer
    • Wels, Oberösterreich, Austria
    • +89 more
    Oct 17, 2022

    Tissue Models for Invasive Disease (TIMID)

    Recruiting
    • Spleen; Septic
      • Leicester, United Kingdom
        UHL NHS Trust - Leicester General Hospital
      May 20, 2022

      Adolescent Idiopathic Scoliosis Trial in Istanbul (Home Based Traditional Scoliosis Exercises, Core Stability Training)

      Recruiting
      • Adolescent Idiopathic Scoliosis
      • Home Based Traditional Scoliosis Exercises
      • Core Stability Training
      • Istanbul, Fatih, Turkey
        Istanbul University
      Sep 24, 2022

      Inborn Errors of Metabolism Trial in Washington (N-carbamylglutamate)

      Unknown status
      • Inborn Errors of Metabolism
      • Washington, District of Columbia
        Childrens Research Institute
      Feb 13, 2020

      Necrobiosis Lipoidica Diabeticorum Trial in Boston (Secukinumab)

      Terminated
      • Necrobiosis Lipoidica Diabeticorum
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 4, 2022

      Anxiety Disorders Trial in New York, Cincinnati (sertraline)

      Recruiting
      • Anxiety Disorders
      • New York, New York
      • +1 more
      Feb 14, 2022

      Biomarker for Krabbe Disease (BioKrabbe)

      Active, not recruiting
      • Krabbe Disease
        • Cairo, Egypt
        • +4 more
        May 12, 2021

        Head Neck Cancer Trial in Caen (Collection of blood samples)

        Recruiting
        • Head and Neck Cancer
        • Collection of blood samples
        • Caen, France
          Centre François Baclesse
        Mar 21, 2022